Lv7
4470 积分 2021-01-05 加入
Peritoneal effusion: an uncommon adverse effect of selective RET inhibitors
3小时前
求助中
More on Selpercatinib and Pseudo-Decreases in Kidney Function
3小时前
求助中
Safety assessment of KRAS (G12C) inhibitors based on the FDA Adverse Event reporting System (FAERS) database: A real-world pharmacovigilance study
4个月前
已完结
A real-world pharmacovigilance study of KRAS G12C mutation inhibitors based on the food and drug administration adverse event reporting system
4个月前
已关闭
Post-marketing safety concern of PI3K inhibitors in the cancer therapies: an 8-year disproportionality analysis from the FDA adverse event reporting system
4个月前
已完结
Risk of Enzyme- and Transporter-Mediated Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application Reviews
7个月前
已完结
Management of sotorasib-related adverse events and hepatotoxicities following anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers and practical guidance proposal
7个月前
已完结
Afatinib treatment of severe respiratory failure due to malignant lymphangitis in a dialysis patient with squamous cell carcinoma of the lung
8个月前
已完结
Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database
8个月前
已完结
皖公网安备34019202002308
